Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Physical activity without weight loss reduces the development of cardiovascular disease risk factors - a prospective cohort study of more than one hundred thousand adults
Indexado
WoS WOS:000517852100017
Scopus SCOPUS_ID:85075887779
DOI 10.1016/J.PCAD.2019.11.010
Año 2020
Tipo revisión

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Purpose: Whether physical activity (PA) might have certain benefits for cardiovascular disease (CVD) primordial prevention even in the absence of clinically significant weight loss is of public health interest. In this study, we examined the independent and combined associations of simultaneous changes in PA and body weight with the subsequent development of major CVD risk factors in adults. Methods: This prospective analysis included 116,134 healthy men and women, aged ≥18 years, with at least 3 medical examinations from the Taiwan MJ Cohort. Two-year changes in PA and body weight between the first and second examination were linked to subsequent development of hypertension, hypercholesterolemia, atherogenic dyslipidemia, metabolic syndrome, type 2 diabetes mellitus (T2DM), and chronic inflammation, which were assessed by physical examinations and laboratory tests. Results: During an average follow-up of 5.7 ± 4.1 years after the second examination, 10,840 individuals developed hypertension, 10,888 hypercholesterolemia, 6078 atherogenic dyslipidemia, 13,223 metabolic syndrome, 4816 T2DM, and 2027 inflammation. Weight gain was associated with a subsequent higher risk of all CVD risk factors, with HR (95%CI) ranging from 1.11 (1.00–1.23) for inflammation to 1.74 (1.67–1.82) for metabolic syndrome, compared with participants who lost weight. A stable weight was also associated with a higher risk of all CVD risk factors except with inflammation. In combined analyses, participants who simultaneously gained weight and decreased PA levels had the highest risk compared with those who lost weight and increased PA. Increasing or maintaining PA reduced the increased subsequent risk of some CVD risk factors among participants who maintained a stable weight or gained weight. Among participants who lost weight, decreased PA was not associated with an increased risk. Conclusions: Although weight loss is crucial for the prevention of CVD risk factors, increasing or maintaining PA is also important to prevent them among adults who gain or maintain their weight.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Cardiac & Cardiovascular Systems
Cardiac & Cardiovascular System
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Martinez-Gomez, David Hombre Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) - España
IMDEA Food Institute - España
UNIV AUTONOMA MADRID - España
CEI UAM CSIC - España
Universidad Autónoma de Madrid - España
2 Lavie, Carl J. Hombre University of Queensland - Australia
The University of Queensland - Australia
UNIV QUEENSLAND - Estados Unidos
The University of Queensland - Estados Unidos
3 Hamer, Mark Hombre UCL - Reino Unido
University College London - Reino Unido
4 Cabanas-Sanchez, Veronica Mujer IMDEA Food Institute - España
CEI UAM CSIC - España
5 Garcia-Esquinas, Esther Mujer Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) - España
UNIV AUTONOMA MADRID - España
Universidad Autónoma de Madrid - España
6 Pareja-Galeano, Helios - Universidad Europea de Madrid - España
Univ Europea Madrid - España
7 Struijk, Ellen Mujer Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) - España
UNIV AUTONOMA MADRID - España
Universidad Autónoma de Madrid - España
8 Sadarangani, Kabir P. Hombre Universidad San Sebastián - Chile
Universidad Diego Portales - Chile
9 Ortega, Francisco B. Hombre Universidad de Granada - España
NOVUM - Suecia
UNIV GRANADA - España
Karolinska Inst - Suecia
Karolinska Institutet - Suecia
10 Rodriguez-Artalejo, Fernando Hombre Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) - España
IMDEA Food Institute - España
UNIV AUTONOMA MADRID - España
CEI UAM CSIC - España
Universidad Autónoma de Madrid - España

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
MJ Health Research Center
Plan Nacional sobre Drogas (Ministry of Health of Spain)
MJ Health Management Institution
FIS
'Ramon y Cajal' contract
Ministry of Health of Spain
Health Research Center
MINECO R+D+I
R+D+I
Plan Nacional sobre Drogas
MJ Health Research Foundation
MINECO R+D+ I grant
MJ Health Research Foundation by MJ Health Research Center

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
This work was supported by Grant 02/2014 from the Plan Nacional sobre Drogas (Ministry of Health of Spain), FIS grants 12/1166 and 16/609 (State Secretary of R+D+I and FEDER/FSE), and MINECO R+D+I grant (DEP2013-47786-R). DM-G is supported by a ?Ramon y Cajal? contract (RYC-2016-20546). The MJ cohort was supported by the MJ Health Management Institution. All data used in this research were authorized by, and received from MJ Health Research Foundation by MJ Health Research Center (Authorization Codes: MJHRF2017006A and MJHRF2017007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
This work was supported by Grant 02/2014 from the Plan Nacional sobre Drogas (Ministry of Health of Spain), FIS grants 12/1166 and 16/609 (State Secretary of R+D+I and FEDER/FSE), and MINECO R+D+ I grant (DEP2013-47786-R). DM -G is supported by a 'Ramon y Cajal' contract (RYC-2016-20546). The MJ cohort was supported by the MJ Health Management Institution. All data used in this research were authorized by, and received from MJ Health Research Foundation by MJ Health Research Center (Authorization Codes: MJHRF2017006A and MJHRF2017007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
This work was supported by Grant 02/2014 from the Plan Nacional sobre Drogas (Ministry of Health of Spain), FIS grants 12/1166 and 16/609 (State Secretary of R+D+I and FEDER/FSE), and MINECO R+D+I grant (DEP2013-47786-R). DM-G is supported by a ?Ramon y Cajal? contract (RYC-2016-20546). The MJ cohort was supported by the MJ Health Management Institution. All data used in this research were authorized by, and received from MJ Health Research Foundation by MJ Health Research Center (Authorization Codes: MJHRF2017006A and MJHRF2017007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
This work was supported by Grant 02/2014 from the Plan Nacional sobre Drogas (Ministry of Health of Spain), FIS grants 12/1166 and 16/609 (State Secretary of R+D+I and FEDER/FSE), and MINECO R+D+I grant (DEP2013-47786-R). DM-G is supported by a ?Ramon y Cajal? contract (RYC-2016-20546). The MJ cohort was supported by the MJ Health Management Institution. All data used in this research were authorized by, and received from MJ Health Research Foundation by MJ Health Research Center (Authorization Codes: MJHRF2017006A and MJHRF2017007A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Muestra la fuente de financiamiento declarada en la publicación.